HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print January 24, 2006

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0905522v1 79/4/757    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clanchy, F. I. L. Articles by Hamilton, J. A. Search for Related Content PubMed PubMed Citation Articles by Clanchy, F. I. L. Articles by Hamilton, J. A.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0905522

Received for publication September 20, 2005.
Revised November 9, 2005.
Accepted for publication November 15, 2005.

Article

Detection and properties of the human proliferative monocyte subpopulation

Felix I. L. Clanchy ^*, Alice C. Holloway ^*, Roya Lari ^*, Paul U. Cameron , and John A. Hamilton ^*@

Departments of *Medicine, Royal Melbourne Hospital, and Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia; and Cooperative Research Centre for Chronic Inflammatory Diseases, Parkville, Victoria, Australia

^@ To whom correspondence should be addressed. E-mail: jahami{at}unimelb.edu.au.

	Abstract

Peripheral blood monocyte subpopulations have been reported and can give rise to diverse, differentiated phenotypes. A subpopulation(s) of human monocytes can proliferate in vitro in response to macrophage-colony stimulating factor (M-CSF; or CSF-1). This population, termed the proliferative monocyte (PM), is presumably less mature than other monocytes; however, it has not been defined further. Previous studies monitoring the frequency of the slowly cycling PM from different donors indicated that the assay for their reproducible measurement required improvement. We demonstrate that for optimal PM detection, high 5-bromo-2`-deoxyuridine concentrations are required over a delayed and wide time-frame. Surface marker phenotyping by flow cytometry showed that freshly isolated PM are CD14⁺ and could be distinguished from two other human monocyte subpopulations, namely, the CD14^loCD16⁺ and CD14^loCD64^- subsets. PM express relatively high levels of CD64 and CD33 but have relatively low CD13 expression; they are also c-Fms⁺ and human leukocyte antigen-DR⁺. Labeling with carboxyfluorescein diacetate succinimidyl ester (CFSE) enabled the estimation of the number of PM divisions over time. Following CFSE labeling and culture, PM were sorted from the nonproliferating population and shown to have a distinctive, spindle-shaped morphology and higher capacity to form multinucleated, tartrate-resistant acid phosphatase⁺ cells in the presence of M-CSF and receptor activator of nuclear factor-B ligand. The phenotype and properties of the PM subpopulation were examined as a prelude to determining its role in disease using methods that can be applied to clarify human monocyte heterogeneity.

Key Words: macrophages • cell proliferation • cell differentiation

This article has been cited by other articles:

				M. A. Venneri, M. D. Palma, M. Ponzoni, F. Pucci, C. Scielzo, E. Zonari, R. Mazzieri, C. Doglioni, and L. Naldini Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer Blood, June 15, 2007; 109(12): 5276 - 5285. [Abstract] [Full Text] [PDF]